Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) ROCE % : 23.47% (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Guangzhou Baiyunshan Pharmaceutical Holdings Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 23.47%.

Guangzhou Baiyunshan Pharmaceutical Holdings Co ROCE % Historical Data

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Baiyunshan Pharmaceutical Holdings Co ROCE % Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.84

14.32

16.22

14.72

13.82

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															25.53	12.45	12.79	4.53	23.47

Guangzhou Baiyunshan Pharmaceutical Holdings Co ROCE % Calculation

Guangzhou Baiyunshan Pharmaceutical Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	6077.79	/	( ( (83379.838 - 41759.676)	+	(85956.668 - 39633.396) )	/ 2 )
	=	6077.79	/	( (41620.162	+	46323.272)	/ 2 )
	=	6077.79	/	43971.717
	=	13.82 %

Guangzhou Baiyunshan Pharmaceutical Holdings Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	11118.4	/	( ( (85956.668 - 39633.396)	+	(85495.716 - 37064.624) )	/ 2 )
	=	11118.4	/	( ( 46323.272	+	48431.092 )	/ 2 )
	=	11118.4	/	47377.182
	=	23.47 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Guangzhou Baiyunshan Pharmaceutical Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) » Definitions » ROCE %

Traded in Other Exchanges

GU5:Germany GU5:Germany 600332:China

Address

89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG

Website

https://www.gybys.com.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.

Executives

Citigroup Inc.	2502 Approved lending agent
Lsv Asset Management	2102 Investment manager
Norges Bank	2101 Beneficial owner
Lsv Asset Management	2102 Investment manager

Guangzhou Baiyunshan Pharmaceutical Holdings Co (HKSE:00874) Headlines

No Headlines